Published: BOPA Delphi consensus guidelines – Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments

The BOPA Guidelines, Advocacy And Publications Committee is pleased to announce that the British Oncology Pharmacy Association Delphi consensus guidelines is now published on the Journal of Oncology Pharmacy Practice.

 

Polwart C, Root T, Tezcan S, et al. British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments. Journal of Oncology Pharmacy Practice. 2024;0(0). doi:10.1177/10781552241243360

The article is available here: https://doi.org/10.1177/10781552241243360

The full article can be accessed by ISOPP members via society complimentary access. Effective as of January 1, 2024, there is no fee for ISOPP membership for all existing and new members regardless of country. Click to find out more or to join ISOPP.

 

Huge congratulations to the following BOPA members:

Calum Polwart mBOPA

Tim Root fBOPA

Songül Tezcan

Bill Wetherill mBOPA

Chloë Waterson mBOPA

Bruce Burnett mBOPA

Rena Chauhan mBOPA

Ibrahim Al-Modaris mBOPA

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article